Company: ACTG
Filing Date: 2025-08-07
Form Type: 10-Q
Source: 0000934549-25-000042
Chunk: 156

Company: ACACIA RESEARCH CORP
Filing Date: 2025-08-07
Form: 10-Q
Item: Part I, Item 8
Chunk 156
---
7 million and $7.5 million for the six months ended June 30, 2025 and 2024, respectively. The Company did not record charges related to impairment of other intangible assets for the six months ended June 30, 2025 and 2024. There was no accelerated amortization of other intangible assets for the six months ended June 30, 2025 and 2024. Intellectual Property Operations amortization of patents was $5.4 million and $3.2 million for the three months ended June 30, 2025 and 2024, respectively, and $9.9 million and $6.7 million for the six months ended June 30, 2025 and 2024, respectively. Intellectual Property Operations amortization of patents is expensed in cost of revenues. Industrial Operations amortization of intangible assets was $433,000 for the three months ended June 30, 2025 and 2024, and $868,000 and $866,000 for the six months ended June 30, 2025 and 2024, respectively. Manufacturing Operations amortization of intangible assets was $427,000 and $899,000 for the three and six months ended June 30, 2025. Industrial Operations and Manufacturing Operations amortization of intangible assets is expensed in general and administrative expenses.The following table presents the scheduled annual aggregate amortization expense (in thousands):Years Ending December 31,Remainder of 2025$12,335 202610,970 20278,510 20284,243 20291,660 20301,660 Thereafter13,580 Total$52,958 During the year ended December 31, 2022, ARG entered into an agreement granting ARG the exclusive option to acquire all rights to license and enforce a patent portfolio and all future patents and patent applications, and incurred $15.0 million 

26

of certain patent and patent rights costs, which was fully paid in 2023. The patent costs are included in prepaid expenses and other current assets in the consolidated balance sheet as of December 31, 2024. During the six months ended June 30, 2025, ARG exercised the option to acquire all rights to license and enforce the portfolio and capitalized $15.0 million in patent and patent rights costs. 

9. ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES

Accru